These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 10688046)
1. Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice. Ikegami S; Harada A; Hirokawa N Neurosci Lett; 2000 Feb; 279(3):129-32. PubMed ID: 10688046 [TBL] [Abstract][Full Text] [Related]
2. Molecular genetics of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Kowalska A Folia Neuropathol; 2002; 40(3):111-8. PubMed ID: 12572916 [TBL] [Abstract][Full Text] [Related]
3. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)]. Kowalska A Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823 [TBL] [Abstract][Full Text] [Related]
4. Frontotemporal dementia with Parkinsonism linked to chromosome-17 mutations enhance tau oligomer formation. Maeda S; Sato Y; Takashima A Neurobiol Aging; 2018 Sep; 69():26-32. PubMed ID: 29852407 [TBL] [Abstract][Full Text] [Related]
5. Tau gene mutations and their effects. Goedert M Mov Disord; 2005 Aug; 20 Suppl 12():S45-52. PubMed ID: 16092090 [TBL] [Abstract][Full Text] [Related]
6. Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations. Goedert M; Satumtira S; Jakes R; Smith MJ; Kamibayashi C; White CL; Sontag E J Neurochem; 2000 Nov; 75(5):2155-62. PubMed ID: 11032905 [TBL] [Abstract][Full Text] [Related]
7. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Clark LN; Poorkaj P; Wszolek Z; Geschwind DH; Nasreddine ZS; Miller B; Li D; Payami H; Awert F; Markopoulou K; Andreadis A; D'Souza I; Lee VM; Reed L; Trojanowski JQ; Zhukareva V; Bird T; Schellenberg G; Wilhelmsen KC Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13103-7. PubMed ID: 9789048 [TBL] [Abstract][Full Text] [Related]
8. Frontotemporal dementia and parkinsonism linked to chromosome 17. Wszołek ZK; Słowiński J; Golan M; Dickson DW Folia Neuropathol; 2005; 43(4):258-70. PubMed ID: 16416390 [TBL] [Abstract][Full Text] [Related]
9. Transgenic zebrafish model of neurodegeneration. Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595 [TBL] [Abstract][Full Text] [Related]
10. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurogenerative process. Goedert M; Ghetti B; Spillantini MG Ann N Y Acad Sci; 2000; 920():74-83. PubMed ID: 11193179 [TBL] [Abstract][Full Text] [Related]
11. Tau phosphorylation in the mouse brain during aversive conditioning. Fujio J; Hosono H; Ishiguro K; Ikegami S; Fujita SC Neurochem Int; 2007; 51(2-4):200-8. PubMed ID: 17597257 [TBL] [Abstract][Full Text] [Related]
12. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Hong M; Zhukareva V; Vogelsberg-Ragaglia V; Wszolek Z; Reed L; Miller BI; Geschwind DH; Bird TD; McKeel D; Goate A; Morris JC; Wilhelmsen KC; Schellenberg GD; Trojanowski JQ; Lee VM Science; 1998 Dec; 282(5395):1914-7. PubMed ID: 9836646 [TBL] [Abstract][Full Text] [Related]
14. [Japanese contribution to the understanding of frontotemporal dementia and parkinsonism linked to chromosome 17(FTDP-17)]. Tsuboi Y; Wszolek ZK; Mizuno Y; Kobayashi T; Yasuda M; Yamada T No To Shinkei; 2003 Feb; 55(2):107-19. PubMed ID: 12684990 [TBL] [Abstract][Full Text] [Related]
15. [Clinical, pathological, and genetic characteristics of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in the MAPT and PGRN]. Tsuboi Y Brain Nerve; 2009 Nov; 61(11):1285-91. PubMed ID: 19938685 [TBL] [Abstract][Full Text] [Related]
16. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains. Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118 [TBL] [Abstract][Full Text] [Related]
17. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. Clausen A; Xu X; Bi X; Baudry M J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441 [TBL] [Abstract][Full Text] [Related]